D. Korovljev, T. Trivic, V. Štajer, P. Drid, Bunpei Sato, S. Ostojić
{"title":"短期吸入H_2改善老年妇女的认知功能:一项初步研究","authors":"D. Korovljev, T. Trivic, V. Štajer, P. Drid, Bunpei Sato, S. Ostojić","doi":"10.6890/IJGE.202005_14(2).0013","DOIUrl":null,"url":null,"abstract":"We analyzed the effects of 4-week H_2 inhalation on cognitive performance in women aged 65 and above. The participants (n = 13) were community-dwelling older women (age 68.0 ± 3.0 years; weight 66.9 ± 10.3 kg; height 161.1 ± 5.8 cm) who volunteered to participate in this open-label pilot trial (ClinicalTrials.gov, NCT02830854). The participants received H_2 by inhalation for 15 min once per day for 4 weeks. The cognitive function was assessed using the Mini Mental State Exam (MMSE) and Alzheimer disease assessment scale cognitive subscale (ADAS-Cog) at baseline and at follow up. H_2 intervention significantly increased total MMSE scores (for 14.2% on average; p < 0.01), thereby improving cognitive function from mild dementia at baseline (a score of 25.6 out of 30) to normal cognition at follow up (above a cut score of 27). In addition, ADAS-Cog scores were significantly improved by H_2 inhalation, with better performance for word recall test (p < 0.01), and improved word recognition (p = 0.01) at post-administration, respectively. This pilot trial seems to corroborate previous animal studies, suggesting that gaseous H_2 might be considered as a beneficial agent for age-related cognitive health.","PeriodicalId":50321,"journal":{"name":"International Journal of Gerontology","volume":"15 1","pages":"149-150"},"PeriodicalIF":0.3000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Short-Term H_2 Inhalation Improves Cognitive Function in Older Women: A Pilot Study\",\"authors\":\"D. Korovljev, T. Trivic, V. Štajer, P. Drid, Bunpei Sato, S. Ostojić\",\"doi\":\"10.6890/IJGE.202005_14(2).0013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We analyzed the effects of 4-week H_2 inhalation on cognitive performance in women aged 65 and above. The participants (n = 13) were community-dwelling older women (age 68.0 ± 3.0 years; weight 66.9 ± 10.3 kg; height 161.1 ± 5.8 cm) who volunteered to participate in this open-label pilot trial (ClinicalTrials.gov, NCT02830854). The participants received H_2 by inhalation for 15 min once per day for 4 weeks. The cognitive function was assessed using the Mini Mental State Exam (MMSE) and Alzheimer disease assessment scale cognitive subscale (ADAS-Cog) at baseline and at follow up. H_2 intervention significantly increased total MMSE scores (for 14.2% on average; p < 0.01), thereby improving cognitive function from mild dementia at baseline (a score of 25.6 out of 30) to normal cognition at follow up (above a cut score of 27). In addition, ADAS-Cog scores were significantly improved by H_2 inhalation, with better performance for word recall test (p < 0.01), and improved word recognition (p = 0.01) at post-administration, respectively. This pilot trial seems to corroborate previous animal studies, suggesting that gaseous H_2 might be considered as a beneficial agent for age-related cognitive health.\",\"PeriodicalId\":50321,\"journal\":{\"name\":\"International Journal of Gerontology\",\"volume\":\"15 1\",\"pages\":\"149-150\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2020-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Gerontology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.6890/IJGE.202005_14(2).0013\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gerontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6890/IJGE.202005_14(2).0013","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Short-Term H_2 Inhalation Improves Cognitive Function in Older Women: A Pilot Study
We analyzed the effects of 4-week H_2 inhalation on cognitive performance in women aged 65 and above. The participants (n = 13) were community-dwelling older women (age 68.0 ± 3.0 years; weight 66.9 ± 10.3 kg; height 161.1 ± 5.8 cm) who volunteered to participate in this open-label pilot trial (ClinicalTrials.gov, NCT02830854). The participants received H_2 by inhalation for 15 min once per day for 4 weeks. The cognitive function was assessed using the Mini Mental State Exam (MMSE) and Alzheimer disease assessment scale cognitive subscale (ADAS-Cog) at baseline and at follow up. H_2 intervention significantly increased total MMSE scores (for 14.2% on average; p < 0.01), thereby improving cognitive function from mild dementia at baseline (a score of 25.6 out of 30) to normal cognition at follow up (above a cut score of 27). In addition, ADAS-Cog scores were significantly improved by H_2 inhalation, with better performance for word recall test (p < 0.01), and improved word recognition (p = 0.01) at post-administration, respectively. This pilot trial seems to corroborate previous animal studies, suggesting that gaseous H_2 might be considered as a beneficial agent for age-related cognitive health.
期刊介绍:
The Journal aims to publish original research and review papers on all fields of geriatrics and gerontology, including those dealing with critical care and emergency medicine.
The IJGE aims to explore and clarify the medical science and philosophy in all fields of geriatrics and gerontology, including those in the emergency and critical care medicine. The IJGE is determined not only to be a professional journal in gerontology, but also a leading source of information for the developing field of geriatric emergency and critical care medicine. It is a pioneer in Asia.
Topics in the IJGE cover the advancement of diagnosis and management in urgent, serious and chronic intractable diseases in later life, preventive medicine, long-term care of disability, ethical issues in the diseased elderly and biochemistry, cell biology, endocrinology, molecular biology, pharmacology, physiology and protein chemistry involving diseases associated with age. We did not limit the territory to only critical or emergency condition inasmuch as chronic diseases are frequently brought about by inappropriate management of acute problems.